Invesco Biotechnology & Genome ETF (PBE) Holdings List

$84.10 0.00 (0.00%)

As of 06/12/2026 04:10 PM Eastern

What stocks does PBE hold?

The Invesco Biotechnology & Genome ETF (PBE) top stock holdings include Illumina, United Therapeutics, and Biogen. The top 25 PBE holdings ordered by weight make up 89.67% of the total fund. PBE is an equity fund in the sector category that invests in publicly traded companies, focused on health care strategies within the North America region. This page includes a complete PBE stock holdings list ranked by weight, along with a full breakdown of sector, geographic, industry, and currency exposure.

Top 25 PBE Holdings

Rank	Company	Current Price	Weight	Shares Held
1	ILMN Illumina	$160.97	6.70%	126,737
2	UTHR United Therapeutics	$545.96	5.76%	32,934
3	BIIB Biogen	$200.05	4.93%	79,805
4	INCY Incyte	$108.53	4.74%	154,149
5	GILD Gilead Sciences	$125.59	4.45%	105,529
6	ALNY Alnylam Pharmaceuticals	$282.85	4.44%	46,766
7	AMGN Amgen	$355.20	4.30%	40,671
8	REGN Regeneron Pharmaceuticals	$612.14	3.90%	20,194
9	VCYT Veracyte	$47.33	3.69%	238,048
10	CPRX Catalyst Pharmaceuticals	$31.36	3.53%	351,223
Get the Latest News and Ratings for PBE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Invesco Biotechnology & Genome ETF and its competitors with MarketBeat's FREE daily newsletter.
11	NBIX Neurocrine Biosciences	$159.76	3.36%	64,905
12	TGTX TG Therapeutics	$49.52	3.35%	278,500
13	RPRX Royalty Pharma	$54.87	3.32%	187,161
14	CDNA CareDx	$22.97	3.23%	441,375
15	ARWR Arrowhead Pharmaceuticals	$74.52	3.22%	133,449
16	BCRX BioCryst Pharmaceuticals	$8.70	3.07%	1,116,443
17	EXEL Exelixis	$53.13	3.04%	188,247
18	PTGX Protagonist Therapeutics	$109.78	2.97%	97,250
19	PTCT PTC Therapeutics	$75.14	2.92%	123,197
20	HALO Halozyme Therapeutics	$69.50	2.64%	120,745
21	RGEN Repligen	$130.59	2.50%	63,103
22	IONS Ionis Pharmaceuticals	$73.28	2.41%	99,400
23	TECH Bio-Techne	$54.00	2.41%	147,484
24	BMRN BioMarin Pharmaceutical	$55.95	2.40%	135,690
25	ACAD ACADIA Pharmaceuticals	$21.09	2.39%	345,522

PBE Geographic Exposure

PBE's largest geographic exposure is United States at 97.2%, followed by Netherlands at 2.8%.

United States
97.2%
Netherlands
2.8%

PBE Currency Exposure

PBE is exclusively exposed to USD.

USD
93.9%

PBE Sector Exposure

PBE's largest sector exposure is Health Care at 97.2%.

Health Care
97.2%

PBE Industry Exposure

PBE's largest industry exposure is Biotechnology at 82.5%, followed by Health Care Equipment & Supplies at 14.7%.

Biotechnology
82.5%
Health Care Equipment & Supplies
14.7%

PBE Sub-Industry Exposure

PBE's largest sub-industry exposure is Biotechnology at 82.5%, followed by Life Sciences Tools & Services at 11.8%.

Biotechnology
82.5%
Life Sciences Tools & Services
11.8%
Health Care Equipment
2.9%

Related Companies and Tools

Related Companies

This page (NYSEARCA:PBE) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Invesco Biotechnology & Genome ETF (PBE) Holdings List